SCHEMBL18483217

SCHEMBL18483217

Cc1ccc(C(C)Nc2nccnc2-c2ccc([N+](=O)[O-])cc2)c(Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.39
▸ THRB P10828 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.38
▸ HPGD P15428 1/20 0.38
▸ KMT2A Q03164 5/20 0.38
▸ MEN1 O00255 3/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ HTR1E P28566 1/20 0.38
▸ S1PR3 Q99500 1/20 0.38
▸ GAA P10253 2/20 0.37
▸ HTT P42858 2/20 0.37
▸ P4HB P07237 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ MMP2 P08253 3/20 0.36
▸ MMP9 P14780 3/20 0.36
▸ MMP8 P22894 3/20 0.36
▸ MMP13 P45452 3/20 0.36
▸ POLB P06746 1/20 0.36
▸ ACHE P22303 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18483213 0.89 ALDH1A1 (0.41) MAPTTHRBALDH1A1HPGDKMT2A
SCHEMBL19205620 0.89 ALDH1A1 (0.41) MAPTTHRBALDH1A1HPGDKMT2A
SCHEMBL19205805 0.88 TAAR1 (0.39) MAPTTHRBALDH1A1KMT2AMEN1
SCHEMBL19205804 0.88 TAAR1 (0.39) MAPTTHRBALDH1A1KMT2AMEN1
SCHEMBL18484101 0.86 KMT2A (0.44) MAPTTHRBALDH1A1HPGDKMT2A
SCHEMBL18484100 0.86 KMT2A (0.44) MAPTTHRBALDH1A1HPGDKMT2A
SCHEMBL18485915 0.83 PIK3CD (0.36) MAPTKMT2AMEN1SMN1; SMN2GAA
SCHEMBL19205745 0.81 MAPT (0.41) MAPTTHRBALDH1A1HPGDKMT2A
SCHEMBL19205746 0.81 MAPT (0.41) MAPTTHRBALDH1A1HPGDKMT2A
SCHEMBL19205688 0.79 MMP2 (0.36) MAPTALDH1A1KMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017021879-A1 NOVEL COMPOUNDS AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2017-02-09 — — WO disclosed
Send feedback